Moxetumomab pasudotox and Sinequan (Doxepin Oral Concentrate)
Determining the interaction of Moxetumomab pasudotox and Sinequan (Doxepin Oral Concentrate) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: doxepin
Brand name: Sinequan, Sinequan, Silenor
Synonyms: Sinequan Capsules, Sinequan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Sinex Long-Acting
- Moxetumomab pasudotox-Sinex Nasal Spray
- Moxetumomab pasudotox-Singulair
- Moxetumomab pasudotox-Singulair (Montelukast Chewable Tablets)
- Moxetumomab pasudotox-Singulair (Montelukast Oral Granules)
- Moxetumomab pasudotox-Singulair (Montelukast Tablets)
- Sinequan (Doxepin Oral Concentrate)-Moxetumomab Pasudotox-tdfk
- Sinequan (Doxepin Oral Concentrate)-Moxetumomab pasudotox-tdfk Intravenous
- Sinequan (Doxepin Oral Concentrate)-Moxifloxacin
- Sinequan (Doxepin Oral Concentrate)-Moxifloxacin (Systemic)
- Sinequan (Doxepin Oral Concentrate)-Moxifloxacin Hydrochloride
- Sinequan (Doxepin Oral Concentrate)-Moxifloxacin Injection